Mode
Text Size
Log in / Sign up

Allergic contact dermatitis

Part of Dermatitis

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for allergic contact dermatitis

7 trials tracked for allergic contact dermatitis: 2 in phase 3 or 4.

7Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 3 1 Phase 2 2 Other / NA 3
  1. Phase 4 Bioequivalence of Ethylenediamine Dihydrochloride Study Completed
  2. Phase 3 The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis Completed
  3. Phase 2 Study of Apremilast in Atopic or Contact Dermatitis Completed
  4. Phase 2 Study of the Intradermal Injection of rHuPH20 or Placebo in Participants With Nickel Allergic Contact Dermatitis Completed
  5. N/A NeoMatriX Wound Matrix Collagen Dressing Skin Prick Test Completed
  6. N/A Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents Completed
Show 1 more trials
  1. N/A Red Grape Polyphenol Oral Administration to Women Affected by Nickel-mediated Allergic Contact Dermatitis Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Dermatitis

Related studies from across the Dermatitis family.

Long-term Safety Profile of Dupilumab in Adults with Moderate to Severe Atopic Dermatitis
Dermatology RCT
Long-term Safety Profile of Dupilumab in Adults with Moderate to Severe Atopic Dermatitis Long-term dupilumab use shows low infection rates in skin conditions
A five-year open-label extension study confirms that dupilumab maintains a favorable safety profile regarding infection rates in adult patie…
A five-year study of adults with moderate to severe atopic dermatitis suggests that long-term dupilumab treatment is not linked to increased…
Upadacitinib 30 mg tops JAK inhibitors for moderate-to-severe atopic dermatitis in network meta-analysis
Dermatology Sys. Review
Upadacitinib 30 mg tops JAK inhibitors for moderate-to-severe atopic dermatitis in network meta-analysis Upadacitinib Shows Highest Efficacy for Moderate to Severe Atopic Dermatitis
A systematic review and network meta-analysis of 9 RCTs (4261 adults) found upadacitinib 30 mg had the highest efficacy for EASI-75, IGA-AD …
A review of data from over 4,000 patients suggests upadacitinib may be the most effective oral treatment among several JAK inhibitors for se…
Topical clobetasol resolves recalcitrant Pagetoid reticulosis in a single case report
Allergy & Immunology Sys. Review
Topical clobetasol resolves recalcitrant Pagetoid reticulosis in a single case report Rare skin condition cleared with common steroid cream
This case report with literature review describes a 53-year-old woman with a 5-year history of a recalcitrant pruritic plaque on the right a…
A woman's stubborn eczema-like rash turned out to a rare skin cancer. A common steroid cream cleared it completely.
Vitamin D supplementation alleviates symptoms of allergic rhinitis, atopic dermatitis, and urticaria
Allergy & Immunology Meta-analysis
Vitamin D supplementation alleviates symptoms of allergic rhinitis, atopic dermatitis, and urticaria Vitamin D shows specific benefits for some allergic skin and respiratory conditions
This umbrella review synthesized data from 66,387 patients regarding vitamin D's role in allergic diseases. The analysis found that vitamin …
New data suggests vitamin D may help manage symptoms of itchy skin and runny noses, though its effects vary by condition.
Routine serum lipid profiles may serve as markers for systemic metabolism in allergic diseases
Allergy & Immunology Sys. Review
Routine serum lipid profiles may serve as markers for systemic metabolism in allergic diseases Blood fat levels may offer clues about asthma severity
This mini review examines the clinical associations of routine serum lipid measures in patients with asthma, atopic dermatitis, and allergic…
New research suggests that routine blood tests for fats like cholesterol could help doctors better understand and categorize different types…
Omalizumab may improve asthma and food allergy in a pediatric liver transplant recipient
Pediatrics Sys. Review
Omalizumab may improve asthma and food allergy in a pediatric liver transplant recipient Omalizumab helps teen with food allergy after liver transplant
A narrative review of a case report describes a 15-year-old boy with a liver transplant and de novo post-transplant food allergy who receive…
A 15-year-old with a liver transplant and severe food allergies improved with omalizumab, gaining asthma control and a less restricted diet.
Nemolizumab Q4W improves IGA success maintenance by 11.8% over withdrawal in atopic dermatitis
Dermatology RCT
Nemolizumab Q4W improves IGA success maintenance by 11.8% over withdrawal in atopic dermatitis Trial shows nemolizumab maintains skin results for atopic dermatitis
This Phase 3 randomized controlled trial evaluated nemolizumab in 507 adolescents and adults with moderate-to-severe atopic dermatitis who w…
A new trial found that nemolizumab helps maintain clear skin and reduce itching for adults and teens with moderate to severe atopic dermatit…
Ultra-processed food consumption is associated with metabolic syndrome, cardiovascular risk, and allergic diseases in children
Nutrition & Obesity Medicine Sys. Review
Ultra-processed food consumption is associated with metabolic syndrome, cardiovascular risk, and allergic diseases in children Ultra-processed foods linked to childhood weight and heart risks
This narrative review synthesizes evidence regarding the impact of ultra-processed food (UPF) on pediatric health. High UPF intake is linked…
High intake of ultra-processed foods is linked to weight gain, metabolic issues, and higher rates of asthma and skin conditions in children.
Upadacitinib Treatment for Concurrent Atopic Dermatitis Vitiligo and Alopecia Areata
Cardiology Sys. Review
Upadacitinib Treatment for Concurrent Atopic Dermatitis Vitiligo and Alopecia Areata One drug improved skin, hair, and pigment in one man
A 57-year-old man with severe, refractory skin conditions showed significant improvement in dermatitis, vitiligo, and hair loss on upadaciti…
A single patient with three skin conditions saw dramatic improvement after taking upadacitinib for one year.
1 514 781 patients shows methylisothiazolinone allergy prevalence is 5.48% in dermatitis cases
Allergy & Immunology Meta-analysis
1 514 781 patients shows methylisothiazolinone allergy prevalence is 5.48% in dermatitis cases Large review shows contact allergy to isothiazolinones affects many dermatitis patients
This systematic review and meta-analysis examined contact allergy prevalence to isothiazolinones in 1 514 781 dermatitis patients from 2000 …
A massive review of over 1.5 million patients found that contact allergy to isothiazolinones is common in dermatitis cases, with methylisoth…
Early preterm birth linked to lower atopic dermatitis risk in large meta-analysis
Dermatology Meta-analysis
Early preterm birth linked to lower atopic dermatitis risk in large meta-analysis Preterm birth linked to lower allergy risk in children
A meta-analysis of observational studies involving over 5 million children found that early preterm birth was associated with a reduced risk…
Babies born early may have lower odds of developing eczema and hay fever, a large analysis finds.
Real-world meta-analysis of baricitinib for atopic dermatitis shows variable outcomes
Dermatology Meta-analysis
Real-world meta-analysis of baricitinib for atopic dermatitis shows variable outcomes Real-world data shows baricitinib helps European patients with severe eczema
This real-world meta-analysis of 264 European patients with moderate-severe atopic dermatitis found that baricitinib improved EASI scores at…
A new analysis of real-world patients found baricitinib reduced eczema severity and itch for many people with moderate-to-severe atopic derm…